TBCRC48 A Phase 2 Study of Olaparib Monotherapy in Metastatic Breast Cancer Patients with Germline or Somatic Mutations in DNA Repair Genes "Olaparib Expanded"
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Johns Hopkins University
Start Date
November 26, 2018
End Date
October 1, 2022
Administered By
Duke Cancer Institute
Awarded By
Johns Hopkins University
Start Date
November 26, 2018
End Date
October 1, 2022